Hematopoietic Stem Cell Transplantation Outcomes in Chronic Myeloid Leukemia Patients in Era of Tyrosine Kinase Inhibitors: A Single Centre Study from Pakistan | Synapse
March 3, 2026
Hematopoietic Stem Cell Transplantation Outcomes in Chronic Myeloid Leukemia Patients in Era of Tyrosine Kinase Inhibitors: A Single Centre Study from Pakistan
Key Points
Improved outcomes were observed in chronic myeloid leukemia patients undergoing hematopoietic stem cell transplantation.
The analysis highlighted a significant association between tyrosine kinase inhibitors and positive transplantation results.
Data were gathered from a single center, emphasizing localized treatment effectiveness.
These findings indicate a need for further exploration of treatment pathways in chronic myeloid leukemia.